Who We Fund: Keeping the Foot on the Pedal

Categories: Blog, Ds Research, News
By Dr. Michael Harpold, LuMind RDS Chief Scientific Officer Dr. Harpold discusses theLuMind RDS research strategy and the importance of nurturing research endeavors through sustained funding. The key objective for the LuMind RDS Research Grants is our mission to stimulate biomedical research that will accelerate the development of safe and effective new therapies to significantly improve cognition, …

Read More

Updates from the LuMind RDS Runners program

Categories: Blog, News, Runners Program
A HUGE THANK YOU to everyone who participated in the World Down Syndrome Day Virtual Run/Walk!  We raised close to $17,000, which was a great success!  Please continue to send us your pictures and stories. We love to hear how you *actively* celebrated WDSD 2016! Where do we stand with bibs for guaranteed entry into …

Read More

Ground-breaking New Scientific Publication on anti-Abeta Vaccine in Preclinical Model of Down Syndrome

Categories: Blog, Clinical Trials, Ds Research, News
By Dr. Michael Harpold, LuMind RDS Chief Scientific Officer AC Immune announced the publication of a ground-breaking scientific study on an anti-A-beta vaccine potentially signaling a way to treat cognitive deficits in people with Down syndrome (Ds). The study, entitled An anti-Abeta-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome, was …

Read More